Stanislas Pol

43.1k citations
487 papers · 19.0k · 4 hit papers · h-index 71

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.05%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 334
    • Liver Disease and Transplantation 30
    • Hepatitis Viruses Studies and Epidemiology 24
    • Hepatitis B Virus Studies 186
    • Liver Disease Diagnosis and Treatment 172

Stanislas Pol

464 papers receiving 18.5k citations

Stanislas Pol's Hit Papers

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study 2015 · 478 citations
4780+8+16Years since publication50010001.5k

Peers

Stanislas Pol
Comparison fields: 5 of 143
  • Hepatology 12.8k
  • Epidemiology 10.5k
  • Transplantation 319
  • Infectious Diseases 2.1k
  • Virology 371
Replace Raymond T. Chung with:
Raymond T. Chung United States
Geoffrey Dusheiko United Kingdom
Ulrich Spengler Germany
Patrick Marcellin France
Heiner Wedemeyer Germany
A. Albertí Italy
Edward Gane New Zealand
Harry L.A. Janssen Netherlands
Janice K. Albrecht United States
Antonio Craxı̀ Italy
Stanislas Pol relative to Raymond T. Chung United States Raymond T. Chung's profile →
Citations per field
00.5×1.5×
Raymond T. Chung · 1×
Citations per year

Countries citing papers authored by Stanislas Pol

Since Specialization
Citations

This map shows the geographic impact of Stanislas Pol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Pol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Pol more than expected).

Fields of papers citing papers by Stanislas Pol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislas Pol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Pol. The network helps show where Stanislas Pol may publish in the future.

Co-authors

The 25 scholars most cited alongside Stanislas Pol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stanislas Pol Line = papers co-authored together Stanislas Pol links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 487 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FIB-4
Hit paper breakdown →
20071648
2
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Hit paper breakdown →
2009771
3
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
Hit paper breakdown →
2002531
4
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Hit paper breakdown →
2015478
5 2001462
6 2011328
7 2017271
8 2007257
9 2012243
10 2008219
11 2003205
12 2014201
13 2015200
14 2016196
15 2005175
16 2004166
17 2019159
18 2010156
19 2009154
20 2004150

About Stanislas Pol

Stanislas Pol is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Immunology, having authored 487 papers that have together received 19.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (334 papers), Hepatitis B Virus Studies (186 papers), Liver Disease Diagnosis and Treatment (172 papers), Systemic Lupus Erythematosus Research (44 papers), HIV/AIDS drug development and treatment (35 papers), Liver Disease and Transplantation (30 papers), Hepatitis Viruses Studies and Epidemiology (24 papers) and Alcohol Consumption and Health Effects (17 papers). The work is most often cited by research in Hepatology (12.8k citations), Epidemiology (10.5k citations), Transplantation (319 citations), Infectious Diseases (2.1k citations) and Virology (371 citations). Stanislas Pol has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Anaïs Vallet‐Pichard, Bertrand Nalpas, Vincent Mallet, Hélène Fontaine, Christian Bréchot, Virginie Verkarre, Valérie Dhalluin-Venier, P. Cacoub, Marc Bourlière and Valérie Thiers. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Viral Hepatitis, Liver International and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact